Kanawha Capital Management LLC Trims Holdings in DENTSPLY SIRONA Inc. (XRAY)

Kanawha Capital Management LLC lowered its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 3.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,781 shares of the medical instruments supplier’s stock after selling 1,200 shares during the quarter. Kanawha Capital Management LLC’s holdings in DENTSPLY SIRONA were worth $1,781,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Vanguard Group Inc. lifted its stake in DENTSPLY SIRONA by 2.5% in the second quarter. Vanguard Group Inc. now owns 22,728,062 shares of the medical instruments supplier’s stock valued at $1,473,688,000 after buying an additional 562,993 shares during the last quarter. Principal Financial Group Inc. lifted its stake in DENTSPLY SIRONA by 22.3% in the second quarter. Principal Financial Group Inc. now owns 6,474,432 shares of the medical instruments supplier’s stock valued at $419,802,000 after buying an additional 1,181,547 shares during the last quarter. Veritas Asset Management LLP lifted its stake in DENTSPLY SIRONA by 2.6% in the second quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock valued at $402,083,000 after buying an additional 157,616 shares during the last quarter. Clearbridge Investments LLC lifted its stake in DENTSPLY SIRONA by 34.6% in the first quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock valued at $328,313,000 after buying an additional 1,353,040 shares during the last quarter. Finally, Epoch Investment Partners Inc. lifted its stake in DENTSPLY SIRONA by 3.5% in the second quarter. Epoch Investment Partners Inc. now owns 3,686,004 shares of the medical instruments supplier’s stock valued at $239,001,000 after buying an additional 123,668 shares during the last quarter. Institutional investors own 93.92% of the company’s stock.

Shares of DENTSPLY SIRONA Inc. (XRAY) traded down 0.52% on Monday, reaching $61.03. The company had a trading volume of 633,847 shares. DENTSPLY SIRONA Inc. has a 12 month low of $52.53 and a 12 month high of $65.68. The company’s market capitalization is $14.01 billion. The stock has a 50 day moving average price of $59.07 and a 200-day moving average price of $60.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.65. The business had revenue of $992.70 million for the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The business’s revenue was down 2.9% on a year-over-year basis. During the same quarter last year, the business posted $0.76 EPS. Analysts forecast that DENTSPLY SIRONA Inc. will post $2.68 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Kanawha Capital Management LLC Trims Holdings in DENTSPLY SIRONA Inc. (XRAY)” was reported by Community Financial News and is the property of of Community Financial News. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.com-unik.info/2017/10/30/kanawha-capital-management-llc-trims-holdings-in-dentsply-sirona-inc-xray.html.

A number of research analysts have recently issued reports on the company. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 target price on the stock in a report on Thursday, July 13th. BidaskClub lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Wednesday, July 19th. HC Wainwright assumed coverage on DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 target price on the stock. Credit Suisse Group reissued an “outperform” rating and issued a $75.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Thursday, July 13th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $69.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Friday, October 6th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $65.60.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

What are top analysts saying about DENTSPLY SIRONA Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DENTSPLY SIRONA Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit